Astrocytes: Targets for neuroprotection in stroke

Central Nervous System Agents in Medicinal Chemistry

Volumn 11, Issue 2, 2011, Pages 164-173

  Barreto, George ^a   White, Robin E ^a   Ouyang, Yibing ^a   Xu, Lijun ^a   Giffard, Rona G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytes; Brain ischemia; Clinical trials; Inflammation; Neurons; Neuroprotection

Indexed keywords

CYTOKINE; GLUCOSE; GLUTAMIC ACID; GLUTATHIONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PEROXYNITRITE; POTASSIUM ION; SUPEROXIDE; VIMENTIN;

ANTIOXIDANT ACTIVITY; ASTROCYTE; BRAIN ISCHEMIA; BRAIN REGION; CELL FUNCTION; CELL SURVIVAL; CELL TYPE; CELL VIABILITY; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; DISEASE SEVERITY; DRUG TARGETING; ENERGY METABOLISM; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; POTASSIUM TRANSPORT; REVIEW; STROKE;

EID: 79959318466     PISSN: 18715249     EISSN: 18756166     Source Type: Journal    
DOI: 10.2174/187152411796011303     Document Type: Review

References (165)

1. Lloyd-Jones, D.; Adams, R. J.; Brown, T. M.; Carnethon, M.; Dai, S.; De Simone, G.; Ferguson, T. B.; Ford, E.; Furie, K.; Gillespie, C.; Go, A.; Greenlund, K.; Haase, N.; Hailpern, S.; Ho, P. M.; Howard, V.; Kissela, B.; Kittner, S.; Lackland, D.; Lisabeth, L.; Marelli, A.; McDermott, M. M.; Meigs, J.; Mozaffarian, D.; Mussolino, M.; Nichol, G.; Roger, V. L.; Rosamond, W.; Sacco, R.; Sorlie, P.; Roger, V. L.; Thom, T.; Wasserthiel-Smoller, S.; Wong, N. D.; Wylie-Rosett, J. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation, 2010, 121, e46-e215.
2. Blakeley, J. O.; Llinas, R. H. Thrombolytic therapy for acute ischemic stroke. J. Neurol. Sci., 2007, 261, 55-62.
3. Marder, V. J.; Jahan, R.; Gruber, T.; Goyal, A.; Arora, V. Thrombolysis with plasmin: implications for stroke treatment. Stroke, 2010, 41, S45-9.
4. Bernard, S. A.; Gray, T. W.; Buist, M. D.; Jones, B. M.; Silvester, W.; Gutteridge, G.; Smith, K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N. Engl. J. Med., 2002, 346, 557-63.
5. Howells, D. W.; Porritt, M. J.; Rewell, S. S.; O'Collins, V.; Sena, E. S.; van der Worp, H. B.; Traystman, R. J.; Macleod, M. R. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J. Cereb. Blood Flow Metab., 30, 1412-31.
6. Kettenmann, H.; Ramson, B. R. Neuroglia, Oxford University Press: New York 1995.
7. Nedergaard, M.; Ransom, B.; Goldman, S. A. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci., 2003, 26, 523-30.
8. Sofroniew, M. V.; Vinters, H. V. Astrocytes: biology and pathology. Acta Neuropathol., 2010, 119, 7-35.
9. Goldberg, M. P.; Choi, D. W. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calciumindependent mechanisms of neuronal injury. J. Neurosci., 1993, 13, 3510-24.
10. Swanson, R. A.; Ying, W.; Kauppinen, T. M. Astrocyte influences on ischemic neuronal death. Curr. Mol. Med., 2004, 4, 193-205.
11. Dringen, R.; Hirrlinger, J. Glutathione pathways in the brain. Biol. Chem., 2003, 384, 505-16.
12. Wilson, J. X. Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol., 1997, 75, 1149-63.
13. Rossi, D. J.; Brady, J. D.; Mohr, C. Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci, 2007, 10, 1377-86.
14. Nedergaard, M.; Dirnagl, U. Role of glial cells in cerebral ischemia. Glia, 2005, 50, 281-6.
15. Ouyang, Y. B.; Voloboueva, L. A.; Xu, L. J.; Giffard, R. G. Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J. Neurosci, 2007, 27, 4253-60.
16. Xu, L.; Emery, J. F.; Ouyang, Y. B.; Voloboueva, L. A.; Giffard, R. G. Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia. Glia, 2010, 58, 1042-9.
17. Anderson, M. F.; Blomstrand, F.; Blomstrand, C.; Eriksson, P. S.; Nilsson, M. Astrocytes and stroke: networking for survival? Neurochem. Res., 2003, 28, 293-305.
18. Giffard, R. G.; Swanson, R. A. Ischemia-induced programmed cell death in astrocytes. Glia, 2005, 50, 299-306.
19. Almeida, A.; Delgado-Esteban, M.; Bolanos, J. P.; Medina, J. M. Oxygen and glucose deprivation induces mitochondrial dysfunction and oxidative stress in neurones but not in astrocytes in primary culture. J. Neurochem., 2002, 81, 207-17.
20. Xu, L.; Sapolsky, R. M.; Giffard, R. G. Differential sensitivity of murine astrocytes and neurons from different brain regions to injury. Exp. Neurol., 2001, 169, 416-24.
21. Zhao, G.; Flavin, M. P. Differential sensitivity of rat hippocampal and cortical astrocytes to oxygen-glucose deprivation injury. Neurosci. Lett., 2000, 285, 177-80.
22. Lukaszevicz, A. C.; Sampaio, N.; Guegan, C.; Benchoua, A.; Couriaud, C.; Chevalier, E.; Sola, B.; Lacombe, P.; Onteniente, B. High sensitivity of protoplasmic cortical astroglia to focal ischemia. J. Cereb. Blood Flow Metab., 2002, 22, 289-98.
23. Bondarenko, A.; Chesler, M. Rapid astrocyte death induced by transient hypoxia, acidosis, and extracellular ion shifts. Glia, 2001, 34, 134-42.
24. Giffard, R. G.; Monyer, H.; Choi, D. W. Selective vulnerability of cultured cortical glia to injury by extracellular acidosis. Brain Res, 1990, 530, 138-41.
25. Swanson, R. A.; Farrell, K.; Stein, B. A. Astrocyte energetics, function, and death under conditions of incomplete ischemia: a mechanism of glial death in the penumbra. Glia, 1997, 21, 142-53.
26. Tombaugh, G. C.; Sapolsky, R. M. Mechanistic distinctions between excitotoxic and acidotic hippocampal damage in an in vitro model of ischemia. J. Cereb. Blood Flow Metab., 1990, 10, 527-35.
27. Chen, Y.; Swanson, R. A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab., 2003, 23, 137-49.
28. Lee, M. H.; Kim, H.; Kim, S. S.; Lee, T. H.; Lim, B. V.; Chang, H. K.; Jang, M. H.; Shin, M. C.; Shin, M. S.; Kim, C. J. Treadmill exercise suppresses ischemia-induced increment in apoptosis and cell proliferation in hippocampal dentate gyrus of gerbils. Life Sci, 2003, 73, 2455-65.
29. Li, Y.; Chopp, M.; Zhang, Z. G.; Zhang, R. L. Expression of glial fibrillary acidic protein in areas of focal cerebral ischemia accompanies neuronal expression of 72-kDa heat shock protein. J. Neurol. Sci., 1995, 128, 134-42.
30. Schroeter, M.; Schiene, K.; Kraemer, M.; Hagemann, G.; Weigel, H.; Eysel, U. T.; Witte, O. W.; Stoll, G. Astroglial responses in photochemically induced focal ischemia of the rat cortex. Exp Brain Res, 1995, 106, 1-6.
31. Van Beek, J.; Chan, P.; Bernaudin, M.; Petit, E.; MacKenzie, E. T.; Fontaine, M. Glial responses, clusterin, and complement in permanent focal cerebral ischemia in the mouse. Glia, 2000, 31, 39-50.
32. Yamashita, K.; Vogel, P.; Fritze, K.; Back, T.; Hossmann, K. A.; Wiessner, C. Monitoring the temporal and spatial activation pattern of astrocytes in focal cerebral ischemia using in situ hybridization to GFAP mRNA: comparison with sgp-2 and hsp70 mRNA and the effect of glutamate receptor antagonists. Brain Res., 1996, 735, 285-97.
33. Liu, D.; Smith, C. L.; Barone, F. C.; Ellison, J. A.; Lysko, P. G.; Li, K.; Simpson, I. A. Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Brain Res. Mol. Brain Res., 1999, 68, 29-41.
34. Dugan, L. L.; Bruno, V. M.; Amagasu, S. M.; Giffard, R. G. Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J. Neurosci., 1995, 15, 4545-55.
35. Rosenberg, P. A.; Aizenman, E. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett., 1989, 103, 162-8.
36. Voloboueva, L. A.; Suh, S. W.; Swanson, R. A.; Giffard, R. G. Inhibition of mitochondrial function in astrocytes: implications for neuroprotection. J. Neurochem., 2007, 102, 1383-94.
37. Chen, J. C.; Hsu-Chou, H.; Lu, J. L.; Chiang, Y. C.; Huang, H. M.; Wang, H. L.; Wu, T.; Liao, J. J.; Yeh, T. S. Down-regulation of the glial glutamate transporter GLT-1 in rat hippocampus and striatum and its modulation by a group III metabotropic glutamate receptor antagonist following transient global forebrain ischemia. Neuropharmacology, 2005, 49, 703-14.
38. Yeh, T. H.; Hwang, H. M.; Chen, J. J.; Wu, T.; Li, A. H.; Wang, H. L. Glutamate transporter function of rat hippocampal astrocytes is impaired following the global ischemia. Neurobiol. Dis., 2005, 18, 476-83.
39. Ito, U.; Hakamata, Y.; Kawakami, E.; Oyanagi, K. Degeneration of astrocytic processes and their mitochondria in cerebral cortical regions peripheral to the cortical infarction: heterogeneity of their disintegration is closely associated with disseminated selective neuronal necrosis and maturation of injury. Stroke, 2009, 40, 2173-81.
40. Ito, U.; Hakamata, Y.; Kawakami, E.; Oyanagi, K. Temporary focal cerebral ischemia results in swollen astrocytic end-feet that compress microvessels and lead to focal cortical infarction. J. Cereb. Blood Flow Metab., 2010.
41. Vangeison, G.; Rempe, D. A. The Janus-faced effects of hypoxia on astrocyte function. Neuroscientist, 2009, 15, 579-88.
42. Bidmon, H. J.; Jancsik, V.; Schleicher, A.; Hagemann, G.; Witte, O. W.; Woodhams, P.; Zilles, K. Structural alterations and changes in cytoskeletal proteins and proteoglycans after focal cortical ischemia. Neuroscience, 1998, 82, 397-420.
43. Yasuda, Y.; Tateishi, N.; Shimoda, T.; Satoh, S.; Ogitani, E.; Fujita, S. Relationship between S100beta and GFAP expression in astrocytes during infarction and glial scar formation after mild transient ischemia. Brain Res., 2004, 1021, 20-31.
44. Smith, G. M.; Strunz, C. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia, 2005, 52, 209-18.
45. Gris, P.; Tighe, A.; Levin, D.; Sharma, R.; Brown, A. Transcriptional regulation of scar gene expression in primary astrocytes. Glia, 2007, 55, 1145-55.
46. Martinez, A. D.; Saez, J. C. Regulation of astrocyte gap junctions by hypoxia-reoxygenation. Brain Res. Brain Res. Rev., 2000, 32, 250-8.
47. Lin, J. H.; Weigel, H.; Cotrina, M. L.; Liu, S.; Bueno, E.; Hansen, A. J.; Hansen, T. W.; Goldman, S.; Nedergaard, M. Gap-junctionmediated propagation and amplification of cell injury. Nat. Neurosci., 1998, 1, 494-500.
48. Wang, W.; Redecker, C.; Yu, Z. Y.; Xie, M. J.; Tian, D. S.; Zhang, L.; Bu, B. T.; Witte, O. W. Rat focal cerebral ischemia induced astrocyte proliferation and delayed neuronal death are attenuated by cyclin-dependent kinase inhibition. J. Clin. Neurosci., 2008, 15, 278-85.
49. Forslin Aronsson, S.; Spulber, S.; Popescu, L. M.; Winblad, B.; Post, C.; Oprica, M.; Schultzberg, M. alpha-Melanocytestimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides, 2006, 40, 65-75.
50. Fang, S. H.; Wei, E. Q.; Zhou, Y.; Wang, M. L.; Zhang, W. P.; Yu, G. L.; Chu, L. S.; Chen, Z. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience, 2006, 140, 969-79.
51. Ye, Y. L.; Shi, W. Z.; Zhang, W. P.; Wang, M. L.; Zhou, Y.; Fang, S. H.; Liu, L. Y.; Zhang, Q.; Yu, Y. P.; Wei, E. Q. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries. Eur. J. Pharmacol., 2007, 557, 23-31.
52. Zhou, Y.; Fang, S. H.; Ye, Y. L.; Chu, L. S.; Zhang, W. P.; Wang, M. L.; Wei, E. Q. Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats. Acta Pharmacol. Sin., 2006, 27, 1103-10.
53. Chung, J. H.; Lee, E. Y.; Jang, M. H.; Kim, C. J.; Kim, J.; Ha, E.; Park, H. K.; Choi, S.; Lee, H.; Park, S. H.; Leem, K. H.; Kim, E. H. Acupuncture decreases ischemia-induced apoptosis and cell proliferation in dentate gyrus of gerbils. Neurol. Res., 2007, 29 Suppl 1, S23-7.
54. del Zoppo, G. J. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience, 2009, 158, 972-82.
55. Kaur, C.; Ling, E. A. Blood brain barrier in hypoxic-ischemic conditions. Curr. Neurovasc. Res., 2008, 5, 71-81.
56. Nawashiro, H.; Brenner, M.; Fukui, S.; Shima, K.; Hallenbeck, J. M. High susceptibility to cerebral ischemia in GFAP-null mice. J. Cereb. Blood Flow Metab., 2000, 20, 1040-4.
57. Li, L.; Lundkvist, A.; Andersson, D.; Wilhelmsson, U.; Nagai, N.; Pardo, A. C.; Nodin, C.; Stahlberg, A.; Aprico, K.; Larsson, K.; Yabe, T.; Moons, L.; Fotheringham, A.; Davies, I.; Carmeliet, P.; Schwartz, J. P.; Pekna, M.; Kubista, M.; Blomstrand, F.; Maragakis, N.; Nilsson, M.; Pekny, M. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab., 2008, 28, 468-81.
58. Kinoshita, A.; Yamada, K.; Kohmura, E.; Hayakawa, T. Effect of astrocyte-derived factors on ischemic brain edema induced by rat MCA occlusion. APMIS, 1990, 98, 851-7.
59. Buchhold, B.; Mogoanta, L.; Suofu, Y.; Hamm, A.; Walker, L.; Kessler, C.; Popa-Wagner, A. Environmental enrichment improves functional and neuropathological indices following stroke in young and aged rats. Restor. Neurol. Neurosci., 2007, 25, 467-84.
60. Keiner, S.; Wurm, F.; Kunze, A.; Witte, O. W.; Redecker, C. Rehabilitative therapies differentially alter proliferation and survival of glial cell populations in the perilesional zone of cortical infarcts. Glia, 2008, 56, 516-27.
61. Popa-Wagner, A.; Badan, I.; Walker, L.; Groppa, S.; Patrana, N.; Kessler, C. Accelerated infarct development, cytogenesis and apoptosis following transient cerebral ischemia in aged rats. Acta Neuropathol., 2007, 113, 277-93.
62. Li, Y.; Chen, J.; Zhang, C. L.; Wang, L.; Lu, D.; Katakowski, M.; Gao, Q.; Shen, L. H.; Zhang, J.; Lu, M.; Chopp, M. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia, 2005, 49, 407-17.
63. Yang, M.; Wei, X.; Li, J.; Heinel, L. A.; Rosenwasser, R.; Iacovitti, L. Changes in Host Blood Factors and Brain Glia Accompanying the Functional Recovery after Systemic Administration of Bone Marrow Stem Cells in Ischemic Stroke Rats. Cell Transplant, 2010.
64. Sharif, A.; Legendre, P.; Prevot, V.; Allet, C.; Romao, L.; Studler, J. M.; Chneiweiss, H.; Junier, M. P. Transforming growth factor alpha promotes sequential conversion of mature astrocytes into neural progenitors and stem cells. Oncogene, 2007, 26, 2695-706.
65. Justicia, C.; Perez-Asensio, F. J.; Burguete, M. C.; Salom, J. B.; Planas, A. M. Administration of transforming growth factor-alpha reduces infarct volume after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab, 2001, 21, 1097-104.
66. Currie, R. W.; Ellison, J. A.; White, R. F.; Feuerstein, G. Z.; Wang, X.; Barone, F. C. Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27. Brain Res., 2000, 863, 169-81.
67. Nakase, T.; Fushiki, S.; Naus, C. C. Astrocytic gap junctions composed of connexin 43 reduce apoptotic neuronal damage in cerebral ischemia. Stroke, 2003, 34, 1987-93.
68. Tuttolomondo, A.; Di Raimondo, D.; di Sciacca, R.; Pinto, A.; Licata, G. Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des., 2008, 14, 3574-89.
69. Lau, L. T.; Yu, A. C. Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury. J. Neurotrauma., 2001, 18, 351-9.
70. Orzylowska, O.; Oderfeld-Nowak, B.; Zaremba, M.; Januszewski, S.; Mossakowski, M. Prolonged and concomitant induction of astroglial immunoreactivity of interleukin-1beta and interleukin-6 in the rat hippocampus after transient global ischemia. Neurosci. Lett., 1999, 263, 72-6.
71. Yang, G. Y.; Gong, C.; Qin, Z.; Liu, X. H.; Lorris Betz, A. Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res. Mol. Brain Res., 1999, 69, 135-43.
72. Wang, Z. Q.; Wu, D. C.; Huang, F. P.; Yang, G. Y. Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia. Brain Res., 2004, 996, 55-66.
73. Huang, J.; Upadhyay, U. M.; Tamargo, R. J. Inflammation in stroke and focal cerebral ischemia. Surg. Neurol., 2006, 66, 232-45.
74. Clark, W. M.; Lutsep, H. L. Potential of anticytokine therapies in central nervous system ischaemia. Exp. Opin. Biol. Ther., 2001, 1, 227-37.
75. Venters, H. D.; Dantzer, R.; Kelley, K. W. Tumor necrosis factoralpha induces neuronal death by silencing survival signals generated by the type I insulin-like growth factor receptor. Ann. N. Y. Acad. Sci., 2000, 917, 210-20.
76. Stoll, G.; Jander, S.; Schroeter, M. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol., 1998, 56, 149-71.
77. Monje, M. L.; Toda, H.; Palmer, T. D. Inflammatory blockade restores adult hippocampal neurogenesis. Science, 2003, 302, 1760-5.
78. Mattson, M. P. NF-kappaB in the survival and plasticity of neurons. Neurochem. Res., 2005, 30, 883-93.
79. Dvoriantchikova, G.; Barakat, D.; Brambilla, R.; Agudelo, C.; Hernandez, E.; Bethea, J. R.; Shestopalov, V. I.; Ivanov, D. Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury. Eur. J. Neurosci., 2009, 30, 175-85.
80. Hoehn, B.; Ringer, T. M.; Xu, L.; Giffard, R. G.; Sapolsky, R. M.; Steinberg, G. K.; Yenari, M. A. Overexpression of HSP72 after induction of experimental stroke protects neurons from ischemic damage. J. Cereb. Blood Flow Metab., 2001, 21, 1303-9.
81. Kim, J. S. Cytokines and adhesion molecules in stroke and related diseases. J. Neurol. Sci., 1996, 137, 69-78.
82. Sofroniew, M. V. Astrocyte failure as a cause of CNS dysfunction. Mol. Psychiatry, 2000, 5, 230-2.
83. Wang, Q.; Tang, X. N.; Yenari, M. A. The inflammatory response in stroke. J. Neuroimmunol, 2007, 184, 53-68.
84. Ali, C.; Nicole, O.; Docagne, F.; Lesne, S.; MacKenzie, E. T.; Nouvelot, A.; Buisson, A.; Vivien, D. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J. Cereb. Blood Flow Metab., 2000, 20, 956-66.
85. Chamorro, A.; Hallenbeck, J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke, 2006, 37, 291-3.
86. del Zoppo, G. J.; Becker, K. J.; Hallenbeck, J. M. Inflammation after stroke: is it harmful? Arch Neurol., 2001, 58, 669-72.
87. Dirnagl, U. Inflammation in stroke: the good, the bad, and the unknown. Ernst. Schering Res. Found. Workshop, 2004, 87-99.
88. Goel, G.; Guo, M.; Ding, J.; Dornbos, D., 3rd; Ali, A.; Shenaq, M.; Guthikonda, M.; Ding, Y. Combined effect of tumor necrosis factor (TNF)-alpha and heat shock protein (HSP)-70 in reducing apoptotic injury in hypoxia: a cell culture study. Neurosci. Lett., 2010, 483, 162-6.
89. Hart, J. Inflammation. 2: Its role in the healing of chronic wounds. J. Wound. Care, 2002, 11, 245-9.
90. Pradillo, J. M.; Fernandez-Lopez, D.; Garcia-Yebenes, I.; Sobrado, M.; Hurtado, O.; Moro, M. A.; Lizasoain, I. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J. Neurochem., 2009, 109, 287-94.
91. Redd, M. J.; Cooper, L.; Wood, W.; Stramer, B.; Martin, P. Wound healing and inflammation: embryos reveal the way to perfect repair. Philos. Trans. R Soc. Lond. B Biol. Sci., 2004, 359, 777-84.
92. Suzuki, M.; Tabuchi, M.; Ikeda, M.; Tomita, T. Concurrent formation of peroxynitrite with the expression of inducible nitric oxide synthase in the brain during middle cerebral artery occlusion and reperfusion in rats. Brain Res., 2002, 951, 113-20.
93. Kader, A.; Frazzini, V. I.; Solomon, R. A.; Trifiletti, R. R. Nitric oxide production during focal cerebral ischemia in rats. Stroke, 1993, 24, 1709-16.
94. Zhang, Q.; Chen, C.; Lu, J.; Xie, M.; Pan, D.; Luo, X.; Yu, Z.; Dong, Q.; Wang, W. Cell cycle inhibition attenuates microglial proliferation and production of IL-1beta, MIP-1alpha, and NO after focal cerebral ischemia in the rat. Glia, 2009, 57, 908-20.
95. Sugawara, T.; Chan, P. H. Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid Redox Signal, 2003, 5, 597-607.
96. Mitrovic, B.; Ignarro, L. J.; Vinters, H. V.; Akers, M. A.; Schmid, I.; Uittenbogaart, C.; Merrill, J. E. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience, 1995, 65, 531-9.
97. Sims, N. R.; Anderson, M. F. Mitochondrial contributions to tissue damage in stroke. Neurochem. Int., 2002, 40, 511-26.
98. Clark, W. M.; Rinker, L. G.; Lessov, N. S.; Lowery, S. L.; Cipolla, M. J. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke, 2001, 32, 1000-4.
99. Cash, D.; Beech, J. S.; Rayne, R. C.; Bath, P. M.; Meldrum, B. S.; Williams, S. C. Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain. Brain Res., 2001, 905, 91-103.
100. Zhao, Z.; Cheng, M.; Maples, K. R.; Ma, J. Y.; Buchan, A. M. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat. Brain Res., 2001, 909, 46-50.
101. Thiyagarajan, M.; Kaul, C. L.; Sharma, S. S. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Br. J. Pharmacol., 2004, 142, 899-911.
102. Bambrick, L.; Kristian, T.; Fiskum, G. Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection. Neurochem. Res., 2004, 29, 601-8.
103. Dringen, R. Metabolism and functions of glutathione in brain. Prog. Neurobiol., 2000, 62, 649-71.
104. Dringen, R.; Gutterer, J. M.; Hirrlinger, J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem., 2000, 267, 4912-6.
105. Lindenau, J.; Noack, H.; Possel, H.; Asayama, K.; Wolf, G. Cellular distribution of superoxide dismutases in the rat CNS. Glia, 2000, 29, 25-34.
106. Sims, N. R.; Nilsson, M.; Muyderman, H. Mitochondrial glutathione: a modulator of brain cell death. J. Bioenerg. Biomembr., 2004, 36, 329-33.
107. Giordano, G.; Kavanagh, T. J.; Costa, L. G. Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE-71. Neurotoxicology, 2009, 30, 326-9.
108. Liu, X. H.; Kato, H.; Nakata, N.; Kogure, K.; Kato, K. An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase in rat hippocampus after transient cerebral ischemia. Brain Res., 1993, 625, 29-37.
109. Bragin, D. E.; Zhou, B.; Ramamoorthy, P.; Muller, W. S.; Connor, J. A.; Shi, H. Differential changes of glutathione levels in astrocytes and neurons in ischemic brains by two-photon imaging. J. Cereb. Blood Flow Metab., 2010, 30, 734-8.
110. Siushansian, R.; Dixon, S. J.; Wilson, J. X. Osmotic swelling stimulates ascorbate efflux from cerebral astrocytes. J. Neurochem., 1996, 66, 1227-33.
111. Hoda, M. N.; Singh, I.; Singh, A. K.; Khan, M. Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat. J. Neuroinflammation., 2009, 6, 21.
112. Rong, Z. T.; Gong, X. J.; Sun, H. B.; Li, Y. M.; Ji, H. Protective effects of oleanolic acid on cerebral ischemic damage in vivo and H(2)O(2)-induced injury in vitro. Pharm. Biol., 2010.
113. Shukla, P. K.; Khanna, V. K.; Ali, M. M.; Khan, M. Y.; Srimal, R. C. Anti-ischemic effect of curcumin in rat brain. Neurochem. Res., 2008, 33, 1036-43.
114. Dhote, V.; Balaraman, R. Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemiareperfusion injury in rats. Clin. Exp. Pharmacol. Physiol., 2008, 35, 630-7.
115. Chan, P. H.; Kawase, M.; Murakami, K.; Chen, S. F.; Li, Y.; Calagui, B.; Reola, L.; Carlson, E.; Epstein, C. J. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J. Neurosci., 1998, 18, 8292-9.
116. Yang, G.; Chan, P. H.; Chen, J.; Carlson, E.; Chen, S. F.; Weinstein, P.; Epstein, C. J.; Kamii, H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke, 1994, 25, 165-70.
117. Kondo, T.; Reaume, A. G.; Huang, T. T.; Carlson, E.; Murakami, K.; Chen, S. F.; Hoffman, E. K.; Scott, R. W.; Epstein, C. J.; Chan, P. H. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J. Neurosci., 1997, 17, 4180-9.
118. Rose, R. C.; Bode, A. M. Biology of free radical scavengers: an evaluation of ascorbate. FASEB J., 1993, 7, 1135-42.
119. Huang, J.; Agus, D. B.; Winfree, C. J.; Kiss, S.; Mack, W. J.; McTaggart, R. A.; Choudhri, T. F.; Kim, L. J.; Mocco, J.; Pinsky, D. J.; Fox, W. D.; Israel, R. J.; Boyd, T. A.; Golde, D. W.; Connolly, E. S., Jr. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc. Natl. Acad. Sci. USA, 2001, 98, 11720-4.
120. Daskalopoulos, R.; Korcok, J.; Tao, L.; Wilson, J. X. Accumulation of intracellular ascorbate from dehydroascorbic acid by astrocytes is decreased after oxidative stress and restored by propofol. Glia, 2002, 39, 124-32.
121. Wang, H. Y.; Wang, G. L.; Yu, Y. H.; Wang, Y. The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats. Brain Res., 2009, 1297, 177-84.
122. Tokumaru, O.; Kuroki, C.; Yoshimura, N.; Sakamoto, T.; Takei, H.; Ogata, K.; Kitano, T.; Nisimaru, N.; Yokoi, I. Neuroprotective effects of ethyl pyruvate on brain energy metabolism after ischemia- reperfusion injury: a 31P-nuclear magnetic resonance study. Neurochem. Res., 2009, 34, 775-85.
123. Haberg, A.; Qu, H.; Saether, O.; Unsgard, G.; Haraldseth, O.; Sonnewald, U. Differences in neurotransmitter synthesis and intermediary metabolism between glutamatergic and GABAergic neurons during 4 hours of middle cerebral artery occlusion in the rat: the role of astrocytes in neuronal survival. J. Cereb. Blood Flow Metab., 2001, 21, 1451-63.
124. Haberg, A. K.; Qu, H.; Sonnewald, U. Acute changes in intermediary metabolism in cerebellum and contralateral hemisphere following middle cerebral artery occlusion in rat. J. Neurochem., 2009, 109 Suppl 1, 174-81.
125. Anderson, C. M.; Swanson, R. A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia, 2000, 32, 1-14.
126. Romera, C.; Hurtado, O.; Botella, S. H.; Lizasoain, I.; Cardenas, A.; Fernandez-Tome, P.; Leza, J. C.; Lorenzo, P.; Moro, M. A. In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor- alpha pathway. J. Neurosci., 2004, 24, 1350-7.
127. Schousboe, A.; Waagepetersen, H. S. Glial modulation of GABAergic and glutamat ergic neurotransmission. Curr. Top. Med. Chem., 2006, 6, 929-34.
128. Westbrook, G. L. Glutamate receptors and excitotoxicity. Res. Publ. Assoc. Res. Nerv. Ment. Dis., 1993, 71, 35-50.
129. Ouyang, C.; Guo, L.; Lu, Q.; Xu, X.; Wang, H. Enhanced activity of GABA receptors inhibits glutamate release induced by focal cerebral ischemia in rat striatum. Neurosci. Lett., 2007, 420, 174-8.
130. Fukamachi, S.; Furuta, A.; Ikeda, T.; Ikenoue, T.; Kaneoka, T.; Rothstein, J. D.; Iwaki, T. Altered expressions of glutamate transporter subtypes in rat model of neonatal cerebral hypoxia-ischemia. Brain Res. Dev. Brain Res., 2001, 132, 131-9.
131. Shen, Y.; He, P.; Fan, Y. Y.; Zhang, J. X.; Yan, H. J.; Hu, W. W.; Ohtsu, H.; Chen, Z. Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity. Free Radic. Biol. Med., 2010, 48, 727-35.
132. Chu, K.; Lee, S. T.; Sinn, D. I.; Ko, S. Y.; Kim, E. H.; Kim, J. M.; Kim, S. J.; Park, D. K.; Jung, K. H.; Song, E. C.; Lee, S. K.; Kim, M.; Roh, J. K. Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation. Stroke, 2007, 38, 177-82.
133. Walz, W. Role of astrocytes in the clearance of excess extracellular potassium. Neurochem. Int., 2000, 36, 291-300.
134. Hansen, A. J. Effect of anoxia on ion distribution in the brain. Physiol. Rev., 1985, 65, 101-48.
135. Kahle, K. T.; Simard, J. M.; Staley, K. J.; Nahed, B. V.; Jones, P. S.; Sun, D. Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology (Bethesda), 2009, 24, 257-65.
136. Leis, J. A.; Bekar, L. K.; Walz, W. Potassium homeostasis in the ischemic brain. Glia, 2005, 50, 407-16.
137. Stanimirovic, D. B.; Ball, R.; Durkin, J. P. Glutamate uptake and Na,K-ATPase activity in rat astrocyte cultures exposed to ischemia. Acta Neurochir. Suppl., 1997, 70, 1-3.
138. Magistretti, P. J. Neuron-glia metabolic coupling and plasticity. J. Exp. Biol., 2006, 209, 2304-11.
139. Caesar, K.; Hashemi, P.; Douhou, A.; Bonvento, G.; Boutelle, M. G.; Walls, A. B.; Lauritzen, M. Glutamate receptor-dependent increments in lactate, glucose and oxygen metabolism evoked in rat cerebellum in vivo. J. Physiol., 2008, 586, 1337-49.
140. Magistretti, P. J.; Pellerin, L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos. Trans. R Soc. Lond. B Biol. Sci., 1999, 354, 1155-63.
141. Cliffe, E. E.; Waley, S. G. The mechanism of the glyoxalase I reaction, and the effect of ophthalmic acid as an inhibitor. Biochem. J., 1961, 79, 475-82.
142. Dienel, G. A.; Hertz, L. Astrocytic contributions to bioenergetics of cerebral ischemia. Glia, 2005, 50, 362-88.
143. Lee, W. H.; Bondy, C. A. Ischemic injury induces brain glucose transporter gene expression. Endocrinology, 1993, 133, 2540-4.
144. Vannucci, S. J.; Reinhart, R.; Maher, F.; Bondy, C. A.; Lee, W. H.; Vannucci, R. C.; Simpson, I. A. Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxiaischemia in the immature rat brain. Brain Res. Dev. Brain Res., 1998, 107, 255-64.
145. Qu, W. S.; Wang, Y. H.; Wang, J. P.; Tang, Y. X.; Zhang, Q.; Tian, D. S.; Yu, Z. Y.; Xie, M. J.; Wang, W. Galectin-1 Enhances Astrocytic BDNF Production and Improves Functional Outcome in Rats Following Ischemia. Neurochem. Res., 2010.
146. Miao, Y.; Qiu, Y.; Lin, Y.; Miao, Z.; Zhang, J.; Lu, X. Protection by pyruvate against glutamate neurotoxicity is mediated by astrocytes through a glutathione-dependent mechanism. Mol. Biol. Rep., 2010.
147. Weller, M. L.; Stone, I. M.; Goss, A.; Rau, T.; Rova, C.; Poulsen, D. J. Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia. Neuroscience, 2008, 155, 1204-11.
148. Wardlaw, J. M.; Sandercock, P. A.; Berge, E. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative metaanalysis. Stroke, 2003, 34, 1437-42.
149. McColl, B. W.; Rothwell, N. J.; Allan, S. M. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci., 2008, 28, 9451-62.
150. Xu, L.; Voloboueva, L. A.; Ouyang, Y.; Emery, J. F.; Giffard, R. G. Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J. Cereb. Blood Flow Metab., 2009, 29, 365-74.
151. Investigators, E. A. S. T. Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology, 2001, 57, 1428-34.
152. Schneider, D.; Berrouschot, J.; Brandt, T.; Hacke, W.; Ferbert, A.; Norris, S. H.; Polmar, S. H.; Schafer, E. Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): an open-label, dose escalation study in patients hospitalized for acute stroke. Eur. Neurol., 1998, 40, 78-83.
153. Mocco, J.; Choudhri, T.; Huang, J.; Harfeldt, E.; Efros, L.; Klingbeil, C.; Vexler, V.; Hall, W.; Zhang, Y.; Mack, W.; Popilskis, S.; Pinsky, D. J.; Connolly, E. S., Jr. HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke. Circ. Res., 2002, 91, 907-14.
154. Wu, O.; Christensen, S.; Hjort, N.; Dijkhuizen, R. M.; Kucinski, T.; Fiehler, J.; Thomalla, G.; Rother, J.; Ostergaard, L. Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI. Brain, 2006, 129, 2384-93.
155. Hampton, D. W.; Seitz, A.; Chen, P.; Heber-Katz, E.; Fawcett, J. W. Altered CNS response to injury in the MRL/MpJ mouse. Neuroscience, 2004, 127, 821-32.
156. Bush, T. G.; Puvanachandra, N.; Horner, C. H.; Polito, A.; Ostenfeld, T.; Svendsen, C. N.; Mucke, L.; Johnson, M. H.; Sofroniew, M. V. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron, 1999, 23, 297-308.
157. Rosenberg, G.; Angel, I.; Kozak, A. Clinical pharmacology of DPb99 in healthy volunteers: first administration to humans. Br. J. Clin. Pharmacol., 2005, 60, 7-16.
158. Abramov, A. Y.; Canevari, L.; Duchen, M. R. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J. Neurosci., 2004, 24, 565-75.
159. Swanson, R. A.; Sharp, F. R. Zinc toxicity and induction of the 72 kD heat shock protein in primary astrocyte culture. Glia, 1992, 6, 198-205.
160. Chen, S. H.; Lin, J. K.; Liu, S. H.; Liang, Y. C.; Lin-Shiau, S. Y. Apoptosis of cultured astrocytes induced by the copper and neocuproine complex through oxidative stress and JNK activation. Toxicol. Sci., 2008, 102, 138-49.
161. Iwata, M.; Inoue, S.; Kawaguchi, M.; Nakamura, M.; Konishi, N.; Furuya, H. Posttreatment but not pretreatment with selective betaadrenoreceptor 1 antagonists provides neuroprotection in the hippocampus in rats subjected to transient forebrain ischemia. Anesth. Analg., 2010, 110, 1126-32.
162. Kikuchi, K.; Tancharoen, S.; Matsuda, F.; Biswas, K. K.; Ito, T.; Morimoto, Y.; Oyama, Y.; Takenouchi, K.; Miura, N.; Arimura, N.; Nawa, Y.; Meng, X.; Shrestha, B.; Arimura, S.; Iwata, M.; Mera, K.; Sameshima, H.; Ohno, Y.; Maenosono, R.; Tajima, Y.; Uchikado, H.; Kuramoto, T.; Nakayama, K.; Shigemori, M.; Yoshida, Y.; Hashiguchi, T.; Maruyama, I.; Kawahara, K. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4. Biochem. Biophys. Res. Commun., 2009, 390, 1121-5.
163. Pettigrew, L. C.; Kasner, S. E.; Gorman, M.; Atkinson, R. P.; Funakoshi, Y.; Ishibashi, H. Effect of arundic acid on serum S-100beta in ischemic stroke. J. Neurol. Sci., 2006, 251, 57-61.
164. Ueno, Y.; Zhang, N.; Miyamoto, N.; Tanaka, R.; Hattori, N.; Urabe, T. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model. Neuroscience, 2009, 162, 317-27.
165. Yenari, M. A.; Xu, L.; Tang, X. N.; Qiao, Y.; Giffard, R. G. Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke, 2006, 37, 1087-93.